These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7560253)

  • 61. Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.
    Finch MB; O'Connor PC; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Apr; 15(4):431-4. PubMed ID: 6849778
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias].
    Dabrowski R; Skrabucha B; Kunicki PK; Kowalik I; Skorykow-Sapińska A; Sitkiewicz D; Sadowski Z
    Pol Arch Med Wewn; 1998 Apr; 99(4):323-30. PubMed ID: 9760820
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.
    Boriani G; Martignani C; Biffi M; Capucci A; Branzi A
    Drugs; 2002; 62(3):415-23. PubMed ID: 11827557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action.
    Faber TS; Camm AJ
    Eur J Clin Pharmacol; 1996; 51(3-4):199-208. PubMed ID: 9010685
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative pharmacological and pharmacokinetic observations on propranolol (long acting formulation) and bendrofluazide administered separately and concurrently to volunteers.
    Nicholls DP; Harron DW; McAinsh J; Castle WM; Barker NP; Shanks RG
    Br J Clin Pharmacol; 1982 Nov; 14(5):727-32. PubMed ID: 7138752
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog.
    Boucher M; Chassaing C; Hamel JD; Poirier JM
    Eur J Pharmacol; 1996 Nov; 315(2):171-7. PubMed ID: 8960881
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
    Belz GG; Essig J; Kleinbloesem CH; Hoogkamer JF; Wiegand UW; Wellstein A
    Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The influence of antiarrhythmic drugs on the exercise-ecg (author's transl)].
    Raff U; Hepp A
    Z Kardiol; 1977 Feb; 66(2):61-5. PubMed ID: 842073
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
    Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of CYP2D6 polymorphisms on the pharmacokinetics of propafenone and its two main metabolites.
    Rouini MR; Afshar M
    Therapie; 2017 Jun; 72(3):373-382. PubMed ID: 28087064
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias.
    Hsieh MH; Chen SA; Wen ZC; Tai CT; Chiang CE; Ding YA; Chang MS
    Int J Cardiol; 1998 Mar; 64(1):37-45. PubMed ID: 9579815
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Propafenone in the conscious dog with chronic atrioventricular block: mechanisms of chronotropic cardiac effects and plasma concentration-response relationships.
    Li JH; Boucher M; Carpentier A; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1986; 8(5):885-91. PubMed ID: 2429086
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The influence of H2-receptor antagonists on steady-state concentrations of propranolol and 4-hydroxypropranolol.
    Donn KH; Powell JR; Rogers JF; Eshelman FN
    J Clin Pharmacol; 1984; 24(11-12):500-8. PubMed ID: 6150946
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.
    Fujimura A; Kumagai Y; Sugimoto K; Nakashima H; Kajiyama H; Ebihara A; Ohashi K
    Eur J Clin Pharmacol; 1990; 38(2):133-7. PubMed ID: 2338109
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A preliminary study on the interaction between ethanol and propranolol in normal human subjects.
    Chakrabarti A; Garg SK; Sharma PL
    Indian J Physiol Pharmacol; 1992 Jul; 36(3):209-12. PubMed ID: 1473855
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical pharmacodynamic studies with cilazapril and a combination of cilazapril and propranolol.
    Erb KA; Essig J; Breithaupt K; Belz GG
    Drugs; 1991; 41 Suppl 1():11-7. PubMed ID: 1712266
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Beta-blocking and electrophysiological effects of propafenone in volunteers.
    Müller-Peltzer H; Greger G; Neugebauer G; Hollmann M
    Eur J Clin Pharmacol; 1983; 25(6):831-3. PubMed ID: 6662183
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.
    Flouvat B; Berlin I; Cournot A; Robinet D; Duchier J; Sarmini H; Rossi A
    Br J Clin Pharmacol; 1989 May; 27(5):539-45. PubMed ID: 2757878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.